XML 50 R21.htm IDEA: XBRL DOCUMENT v3.25.1
FINANCIAL INSTRUMENTS AT FAIR VALUE
 12 Months Ended
Dec. 31, 2024
Investments, All Other Investments [Abstract]  
FINANCIAL INSTRUMENTS AT FAIR VALUE

NOTE 11: FINANCIAL INSTRUMENTS AT FAIR VALUE

 

Financial instruments:

 

The Company has financial instruments measured at level 3 from the June 2024 Facility Agreement (see note 10.E).

 

The fair value of the financial instruments under the June 2024 Facility Agreement, as of December 31, 2024, was calculated using the following unobservable inputs: share price: $0.472, expected volatility: 148%, exercise price: $1.00, risk-free interest rate: 4.24%-4.32%, expected life: 0.46-0.50 years.

 

The following table presents the financial instruments that were measured at fair value through profit or loss:

 

   Embedded derivatives 
Balance as of January 1, 2024   - 
Embedded derivatives recorded in connection with June 2024 Facility Agreement   40 
Net changes at fair value recognized through profit or loss   (11)

Balance as of December 31, 2024

   29